Prevalence of Non- Prevalence of Non -O157 Shiga Toxin O157 Shiga - - PowerPoint PPT Presentation

prevalence of non prevalence of non o157 shiga toxin o157
SMART_READER_LITE
LIVE PREVIEW

Prevalence of Non- Prevalence of Non -O157 Shiga Toxin O157 Shiga - - PowerPoint PPT Presentation

Prevalence of Non- Prevalence of Non -O157 Shiga Toxin O157 Shiga Toxin- -Producing Producing Escherichia coli Escherichia coli in Live Animals and at Various Steps During Harvest in Live Animals and at Various Steps During Harvest Terry


slide-1
SLIDE 1

Terry Arthur Terry Arthur USDA USDA-

  • ARS

ARS-

  • MARC

MARC Prevalence of Non Prevalence of Non-

  • O157 Shiga Toxin

O157 Shiga Toxin-

  • Producing

Producing Escherichia coli Escherichia coli in Live Animals and at Various Steps During Harvest in Live Animals and at Various Steps During Harvest

slide-2
SLIDE 2

Outline Outline

  • Introduction

Introduction

  • Detection/Isolation of non

Detection/Isolation of non-

  • O157 STEC

O157 STEC

  • Non

Non-

  • O157 STEC prevalence in cattle

O157 STEC prevalence in cattle

  • Non

Non-

  • O157 STEC prevalence on beef carcasses

O157 STEC prevalence on beef carcasses

  • Conclusion

Conclusion

slide-3
SLIDE 3

S Shiga higa t toxin

  • xin-
  • producing

producing E Escherichia scherichia c coli

  • li (STEC)

(STEC)

  • Foodborne pathogens

Foodborne pathogens

  • Cause serious disease and death in humans

Cause serious disease and death in humans

  • Cattle serve as reservoir

Cattle serve as reservoir

X X

slide-4
SLIDE 4

Shiga Shiga-

  • like toxin (SLTEC)

like toxin (SLTEC) Vero toxin (VTEC) Vero toxin (VTEC) Shiga toxin (STEC) Shiga toxin (STEC) Nomenclature Nomenclature

  • Shiga toxin initially discovered as a product of

Shiga toxin initially discovered as a product of Shigella dysenteriae Shigella dysenteriae

  • Antibodies against Shiga toxin shown to inhibit

Antibodies against Shiga toxin shown to inhibit cytotoxicity cytotoxicity of an

  • f an E.

E. coli coli strain strain

  • E. coli
  • E. coli strain discovered to be toxic to vero cells

strain discovered to be toxic to vero cells E Entero nteroh hemorrhagic emorrhagic E E. . c coli

  • li (EHEC

(EHEC) ) Cause disease in humans Cause disease in humans

slide-5
SLIDE 5

Non Non-

  • O157 STEC

O157 STEC Estimated to cause one Estimated to cause one-

  • third of the clinical EHEC cases,

third of the clinical EHEC cases, however, this is probably an underestimation. however, this is probably an underestimation. Over 200 STEC serotypes have been isolated from cattle. Over 200 STEC serotypes have been isolated from cattle. The proportion of non The proportion of non-

  • O157 STEC able to cause disease

O157 STEC able to cause disease in humans is unknown. in humans is unknown.

slide-6
SLIDE 6

Y Y

Lipopolysaccharide (LPS) Lipopolysaccharide (LPS) Flagella Flagella = H antigen = H antigen = O antigen = O antigen H1 H1-

  • H56

H56 O1 O1-

  • O173

O173

  • E. coli
  • E. coli serotyping

serotyping O157:H7 O157:H7 O111:H8 O111:H8 O26:H11 O26:H11

slide-7
SLIDE 7

Non Non-

  • O157 disease outbreaks in U.S.

O157 disease outbreaks in U.S.

Montana Montana O104:H21 11 persons O104:H21 11 persons milk? milk? 1994 1994 Connecticut Connecticut O121:H19 11 persons swimming in lake O121:H19 11 persons swimming in lake 1999 1999 Texas Texas O111:H8 58 persons O111:H8 58 persons ice? ice? 1999 1999

Approximately 35 Approximately 35 E. coli

  • E. coli O157 outbreaks occur each

O157 outbreaks occur each year, but only 3 non year, but only 3 non-

  • O157 outbreaks ever reported in

O157 outbreaks ever reported in the U.S. the U.S.

slide-8
SLIDE 8

Non Non-

  • O157 STEC disease in US

O157 STEC disease in US

O2.H7 HUS O83.H1 HUS O121.H19 HUS/D O4.H- HC O85.H- D O125.H- BD/HUS O5.H- BD/HUS O88.H- D O126.H27 HUS O14.H- HUS O103.H2 BD/HUS O137.H41 HUS O22.H5 HUS O103.H2 HUS O145.H- HUS/BD O26.H11 BD/HUS O103.H25 D/BD O153.H2 BD/HUS O26.H2 D O103.H6 D O165.H25 HUS/BD O38.H21 D O104.H- BD/HUS O172.H- HUS/D O45.H2 BD/HUS O104.H2 BD O?.H11 BD/HUS O45.H2 HC O111.H- HUS OR.H- HUS O48.H21 BD O111.H8 BD/HUS OR.H9 BD/HUS O50.H7 BD/HUS O113.H21 BD/HUS OR:H2 D O68.H- BD/HUS O118.H16 BD OX3.H21 HUS O79.H7 HUS O119.H- D

HUS HUS – – hemolytic uremic syndrome hemolytic uremic syndrome HC HC – – hemorrhagic colitis hemorrhagic colitis BD BD – – bloody diarrhea bloody diarrhea D D – – diarrhea diarrhea

slide-9
SLIDE 9

STEC virulence factors STEC virulence factors

Shiga toxins Shiga toxins – – two types: two types: stx stx1 and 1 and stx stx2 2

  • ribosome inactivating proteins

ribosome inactivating proteins Intimin ( Intimin (eae) eae) – – attachment to epithelial cells attachment to epithelial cells EHEC EHEC-

  • hemolysin

hemolysin – – iron acquisition? iron acquisition?

slide-10
SLIDE 10

Family: Enterobacteriaceae Family: Enterobacteriaceae Gram negative Gram negative Rod Rod-

  • shaped

shaped Motile Motile Ferment: several sugars Ferment: several sugars including sorbitol including sorbitol β β-

  • glucuronidase positive

glucuronidase positive

  • E. coli
  • E. coli
slide-11
SLIDE 11

Family: Enterobacteriaceae Family: Enterobacteriaceae Gram negative Gram negative Rod Rod-

  • shaped

shaped Motile: flagella Motile: flagella Ferment: several sugars Ferment: several sugars not not sorbitol sorbitol β β-

  • glucuronidase

glucuronidase negative negative

  • E. coli
  • E. coli O157

O157

Produce Shiga toxins Produce Shiga toxins Infectious dose <50 organisms Infectious dose <50 organisms

slide-12
SLIDE 12

Family: Enterobacteriaceae Family: Enterobacteriaceae Gram negative Gram negative Rod Rod-

  • shaped

shaped Motile: flagella Motile: flagella Ferment: several sugars Ferment: several sugars including sorbitol including sorbitol β β-

  • glucuronidase positive

glucuronidase positive

Non Non-

  • O157 STEC

O157 STEC

Produce Shiga toxins Produce Shiga toxins Infectious dose ~10 organisms Infectious dose ~10 organisms

slide-13
SLIDE 13

Non Non-

  • O157 STEC Detection

O157 STEC Detection

  • Sampling is the same as for O157

Sampling is the same as for O157

  • Enrichment is the same as for O157

Enrichment is the same as for O157 Detection has focused on identification of strains carrying the Detection has focused on identification of strains carrying the Shiga toxin genes or expressing the toxin proteins Shiga toxin genes or expressing the toxin proteins PCR PCR EIA EIA Colony hybridization Colony hybridization Vero cell assay Vero cell assay

  • No universal

No universal immunomagnetic immunomagnetic separation method available separation method available

  • Cannot use sorbitol

Cannot use sorbitol-

  • based detection

based detection

  • Cannot use

Cannot use β β-

  • glucuronidase

glucuronidase-

  • based detection

based detection

slide-14
SLIDE 14

Vero Cell Assay (VCA) Vero Cell Assay (VCA)

A cultured cell line, vero cells, is grown with the addition of A cultured cell line, vero cells, is grown with the addition of culture culture supernatant in supernatant in microtiter microtiter plates. plates. After incubation for 48 to 72 hours, the After incubation for 48 to 72 hours, the microtiter microtiter plates are examined plates are examined microscopically. microscopically. Killing of the Vero cells is considered presumptive evidence of Killing of the Vero cells is considered presumptive evidence of the the presence of Shiga toxins in the broth culture supernatants. presence of Shiga toxins in the broth culture supernatants. Other organisms may produce toxins unrelated to Shiga toxins but Other organisms may produce toxins unrelated to Shiga toxins but toxic to toxic to Vero cells. To avoid false positive samples, antibodies which n Vero cells. To avoid false positive samples, antibodies which neutralize eutralize both Stx1 and Stx2 are used. both Stx1 and Stx2 are used. All positive samples are streaked for isolated colonies, which a All positive samples are streaked for isolated colonies, which are then re then tested by the same assay or by PCR to isolate STEC strains. tested by the same assay or by PCR to isolate STEC strains.

slide-15
SLIDE 15

Enzyme Enzyme-

  • Immunoassay (EIA)

Immunoassay (EIA)

Enzyme Enzyme-

  • immunoassays use anti

immunoassays use anti-

  • Shiga toxin antibodies to capture and

Shiga toxin antibodies to capture and detect the toxins in culture supernatants. detect the toxins in culture supernatants. 96 96-

  • well format

well format Commercially available Commercially available Test samples Test samples -

  • then individual isolates

then individual isolates

slide-16
SLIDE 16
  • Hemolysin

Hemolysin

  • Intimin

Intimin

  • Shiga toxin 2

Shiga toxin 2

  • Shiga toxin 1

Shiga toxin 1

PCR PCR

DNA primers for specific virulence factor genes Can identify multiple genes in one reaction Detects viable and nonviable cells

slide-17
SLIDE 17

Colony hybridization Colony hybridization

Grow colonies from sample enrichments on agar media Grow colonies from sample enrichments on agar media Transfer colonies to nylon membranes Transfer colonies to nylon membranes Lyse Lyse cells and fix DNA to the membrane cells and fix DNA to the membrane Hybridize with DNA probe Hybridize with DNA probe Detect bound probe Detect bound probe Identify target colonies Identify target colonies

slide-18
SLIDE 18

STEC Plating STEC Plating

  • EC agar with 1% glucose
slide-19
SLIDE 19
slide-20
SLIDE 20

Before After

slide-21
SLIDE 21
slide-22
SLIDE 22
slide-23
SLIDE 23
slide-24
SLIDE 24

Biochemical tests are required to confirm isolates are E. coli Shigella dysenteriae, Citrobacter freundii, and Enterobacter cloacae have been found to produce Shiga toxins.

Confirmation of STEC Confirmation of STEC

slide-25
SLIDE 25

Country Country Prevalence Method Prevalence Method Reference Reference United States United States 5.9% 5.9% colony hybridization colony hybridization Cray et al. 1996 Cray et al. 1996 19% 19% vero cell assay vero cell assay Wells et al. 1991 Wells et al. 1991 Argentina Argentina 37% 37% vero cell assay vero cell assay Blanco et al. 1997 Blanco et al. 1997 Canada Canada 38.2% 38.2% vero cell assay vero cell assay Van Donkersgoed et al. 1999 Van Donkersgoed et al. 1999 France France 70% 70% PCR PCR Pradel Pradel et al. 2000 et al. 2000 Japan Japan 78.9% 78.9% PCR PCR Shinagawa et al. 2000 Shinagawa et al. 2000 100% 100% nested PCR nested PCR Kobayashi et al. 2001 Kobayashi et al. 2001

Prevalence of non Prevalence of non-

  • O157 STEC in Cattle

O157 STEC in Cattle

slide-26
SLIDE 26

Prevalence of STEC in Cattle Prevalence of STEC in Cattle Calves appear to be more susceptible to STEC colonization Calves appear to be more susceptible to STEC colonization than older cows. than older cows. STEC strains harboring STEC strains harboring stx stx1 are more commonly isolated from 1 are more commonly isolated from cattle than those harboring cattle than those harboring stx stx2. 2. Bovine Bovine-

  • related STEC isolates lack accessory virulence factors

related STEC isolates lack accessory virulence factors intimin and hemolysin intimin and hemolysin EHEC serotypes (O157:H7, O111:H8, and O26:H11) are EHEC serotypes (O157:H7, O111:H8, and O26:H11) are infrequently isolated form cattle when using unbiased methods. infrequently isolated form cattle when using unbiased methods.

slide-27
SLIDE 27

Prevalence of non Prevalence of non-

  • O157 STEC on beef carcasses at processing

O157 STEC on beef carcasses at processing Sampled beef cattle carcasses at four large beef processing plants in Midwestern U.S. during the summer months Samples collected for a survey of E. coli O157:H7 prevalence Carcasses were followed through processing Samples were taken after dehiding but prior to evisceration (preevisceration) and after all antimicrobial interventions when carcasses were in cooler (postprocessing)

slide-28
SLIDE 28

Surveyed for E. coli O157

  • E. coli O157 negative samples
  • E. coli O157 positive samples

Screen sample enrichments by PCR for stx1 & stx2 genes Cannot use PCR to screen

PCR Screening

All positive for stx1 or stx2 genes proceed to colony blotting Proceed to colony blotting

slide-29
SLIDE 29

8/13 (61.5) 1/13 (7.6) 1/10 (10.0) Preevisceration Postprocessing A 1 1 84 6/18 (33.3) 0/18 (0) 2 35 5/8 (62.5) 1/7 (14.3) 3 68 1/15 (6.7) 0/16 (0) 2 1 80 14/18 (77.8) 2/18 (11.1) 2 41 8/10 (80.0) 2/9 (22.2) 3 62 11/14 (78.6) 2/13 (15.4) B 1 1 46 0/11 (0) 0/9 (0) 2 37 0/9 (0) 0/9 (0) 3 39 6/9 (66.7) 1/9 (11.1) 4 48 3/12 (25.0) 2/12 (16.7) 2 1 36 2/9 (22.2) 0/9 (0) 2 36 6/8 (75.0) 0/9 (0) 3 36 8/9 (88.9) 0/7 (0) C 1 1 41 6/10 (60.0) 0/10 (0) 2 76 10/17 (58.8) 1/17 (5.9) 3 42 7/10 (70.0) 1/10 (10.0) 4 38 10/10 (100) 2/9 (22.2) 2 1 38 10/10 (100) 0/10 (0) 2 44 5/9 (55.6) 1/10 (10.0) 3 40 9/11 (81.8) 2/11 (18.2) D 1 1 37 4/7 (57.1) 1/8 (12.5) 2 39 4/7 (57.1) 1/5 (20.0) 3 38 2/8 (25.0) 0/8 (0) 4 42 1/8 (12.5) 2/8 (25.0) 2 1 65 4/14 (28.6) 0/13 (0) 2 42 2/11 (18.2) 0/11 (0) Plant Sample Period Lot n Positive Samples Positive Samples 4 44 4 40 10/10 (100) 4 46 9/12 (75.0) 4/12 (33.3) 3 58 9/17 (52.9) 0/16 (0) Cumulative Totals 180/334 (53.9) 27/326 (8.3)

slide-30
SLIDE 30

Total 334 326 stx PCR Positive 146 (77%) 43 (13%) Total non-O157 STEC positive 180 (54%) 27 (8%) Samples Preevisceration Postprocessing Total STEC positive 240 (72%) 33 (10%) 290 (87%) 49 (15%) Total stx positive Non-O157 STEC positive 96 (51%) 27 (8%) Non-O157 STEC positive 84 (58%) 0 (0%) O157:H7 positive 144 6 O157:H7 negative 190 320

slide-31
SLIDE 31

Prevalence of Non-O157 Contamination of Beef Cattle Carcasses

U.S. France1 Hong Kong2 Total Samples 326 851 986

1Rogerie et al., 2001. 2Leung et al., 2001.

Total non-O157 STEC positive 27 (8.3) 16 (1.9) 17 (1.7) PCR positive for stx genes 43 (13.4)3 91 (10.7) 112 (11.4)

3PCR performed on 320 of the 326 samples.

slide-32
SLIDE 32

Virulence of Virulence of

  • rganism
  • rganism

Dose Dose Immune status Immune status

  • f individual
  • f individual

Determinants of infection Determinants of infection

slide-33
SLIDE 33

Virulence attributes Virulence attributes

  • Shiga toxin 2 has lower LD

Shiga toxin 2 has lower LD50

50 for mice than Shiga toxin 1.

for mice than Shiga toxin 1.

  • Individuals infected with strains producing Shiga toxin 2 are

Individuals infected with strains producing Shiga toxin 2 are more likely to develop severe disease than those infected with more likely to develop severe disease than those infected with strains carrying Shiga toxin 1. strains carrying Shiga toxin 1.

  • STEC strains producing intimin and EHEC

STEC strains producing intimin and EHEC-

  • hemolysin frequently

hemolysin frequently associated with severe disease in humans. associated with severe disease in humans.

slide-34
SLIDE 34

stx1 152 135 17 stx2 93 78 15 stx1, stx2 15 15 stx1, eae 2 2 stx1, hlyA 8 3 5 stx2, hlyA 19 17 2 stx1, stx2, hlyA 31 23 8 stx1, stx2, eae 1 1 stx1, eae, hlyA 8 6 2 stx2, eae, hlyA 20 20 STEC virulence factors # of Isolates Preevis Post stx1, stx2, eae, hlyA 12 10 2 Total 361 310 51

slide-35
SLIDE 35

Serotypes Serotypes

  • In the U.S., O26 and O111 are the two most common

In the U.S., O26 and O111 are the two most common serogroups of clinical STEC isolates. serogroups of clinical STEC isolates.

  • Other serogroups commonly associated with human

Other serogroups commonly associated with human disease in the U.S. and abroad are O91, O103, O113, & disease in the U.S. and abroad are O91, O103, O113, & O121 O121

www.sciencenet.com.au/vtectable.htm www.sciencenet.com.au/vtectable.htm

slide-36
SLIDE 36

O142 O121 O2 O171 O113 O132 O8 O88 O6 O139 O172 OX3 O104 O117 O15 O165 O3 O55 O153 O168 O10 O45 O103 O109 O119 O145

Serogroup

OX25

Serogroup distribution of non Serogroup distribution of non-

  • O157 STEC isolates

O157 STEC isolates

# of

54 46 8 47 2 5 31 31 2 27 2 22 19 3 4 13 5 18 18 6 12 15 12 3 1 10 4 14 13 1 11 3 13 11 2 2 1 4 6 10 10 5 2 2 1 9 8 1 1 1 7 9 5 4 4 5 9 7 2 9 9 3 6 6 3 5 1 4 2 3 5 5 4 1 4 4 3 1 4 4 2 1 1 3 3 2 1 3 3 2 1 3 3 1 2 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2

Plants isolates Preevis Post A B C D

2 2 2

slide-37
SLIDE 37

bovine bovine human human

Conclusion Conclusion

bovine bovine human human

  • Majority of bovine STEC strains lack accessory virulence

Majority of bovine STEC strains lack accessory virulence factors and are potentially less virulent. factors and are potentially less virulent.

  • Cannot distinguish between virulent and nonvirulent STEC.

Cannot distinguish between virulent and nonvirulent STEC.

slide-38
SLIDE 38

Mohammad Koohmaraie Mohammad Koohmaraie Genevieve Barkocy Genevieve Barkocy-

  • Gallagher

Gallagher Mildred Rivera Mildred Rivera-

  • Betancourt

Betancourt Dee Kucera Dee Kucera Frank Reno Frank Reno Acknowledgements Acknowledgements

slide-39
SLIDE 39

non-O157 STEC (+) 180 / 334 (54%) 27 / 326 (8%) Total STEC pos 240 /334 (72%) 33 / 326 (10%) Samples Preevisceration Postprocessing Total Samples 334 326 60 / 334 (18%) O157 (+) & Non-O157 STEC (-) 6 / 326 (2%) 27 / 326 (8%) O157 (-) & Non-O157 STEC (+) 96 / 334 (29%) 84 / 334 (25%) O157 (+) & Non-O157 STEC (+) 0 / 326 (0%) O157 (+) Samples 6 / 326 (2%) 144 / 334 (43%)